Alert

Kelly Brunk, PharmD

PGY2 Oncology


Education

PGY1: Thomas Jefferson University Hospital

Pharmacy School: The University of Kansas

Hometown

Kansas City, MO

Research

PGY1: Clinical and financial outcomes of an anticoagulant transition of care model

Why UNC

The PGY2 hematology/oncology residency at UNC offers much more than learning how to be a clinical specialist in oncology pharmacy. It develops residents into change-makers, teachers, researchers, critical thinkers, and team players. In the US, UNC is the leader in pharmacy. Its voice reaches beyond our country's border, improving practice models and patient care across the globe. Residents can participate in international rotations as well as numerous community outreach events. Through these efforts and others, UNC promotes leadership, empathy, diversity, and inclusion.

The residency also provides a myriad of diverse rotations that challenge and expand the resident's breadth and depth of knowledge under the guidance of excellent preceptors. In summation, the PGY2 hematology/oncology residency at UNC is a fantastic residency that stimulates holistic growth, both personally and professionally.

For more information contact:

Kamakshi Rao

Kamakshi Rao, PharmD, BCOP, CPP, FASHP
Clinical Manager in Education, Research, and Practice Training
Top